H. Schroeder

Sustained release from inert wax matrixes I: drug-wax combinations.

P. Deluca, H. Schroeder, A. Dakkuri, 1978, Journal of pharmaceutical sciences.

Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal Techniques

P. Deluca, H. Schroeder, M. Kanke, 2004, Pharmaceutical Research.

Physiological effects of subvisible microspheres administered intravenously to beagle dogs.

B. Bivins, P. Deluca, H. Schroeder, 1978, Journal of pharmaceutical sciences.

Physical-chemical properties of substituted amides in aqueous solution and evaluation of their potential use as solubilizing agents.

L. Lachman, P. Deluca, H. Schroeder, 1973, Journal of pharmaceutical sciences.

Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.

P. Deluca, H. Schroeder, 1976, American journal of hospital pharmacy.

Distribution of radiolabeled subvisible microspheres after intravenous administration to beagle dogs.

P. Deluca, H. Schroeder, G. Simmons, 1978, Journal of pharmaceutical sciences.

Sustained release from inert wax matrixes II: effect of surfactants on tripelennamine hydrochloride release.

P. Deluca, H. Schroeder, A. Dakkuri, 1978, Journal of pharmaceutical sciences.

An approach to setting particulate matter standards for small volume parenterals.

P. Deluca, H. Schroeder, D. Haack, 1986, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

Separation of boron isotopes by direct mode thermal parametric pumping

C. Hamrin, H. Schroeder, 1975 .

Sterility Assurance with Filtration Taking Bioburden , Membrane Integrity , and Process Conditions into Account

H. Schroeder, 2006 .